Sponsor content

Looking for the collaboration of a lifetime

Whilst continuing to nurture its existing collaborations, GSK is seeking new partners—from academia to biotech and pharma—to harness the skills and expertise of scientists and enable the creation of the next generation of vaccines.

Go to the profile of GSK
Jun 02, 2017
0
0
Page of
Go to the profile of GSK

GSK

GSK is one of the world’s leading vaccine companies, involved in vaccine research, development and production. We have 15 vaccines in development and our broad portfolio of 39 vaccines prevent illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis. Globally, we have more than 16,000 people working to deliver nearly 2 (1.9) million vaccines every day, to people in around 90% (172) of the world’s countries. In 2015 we distributed around 690 million doses of vaccine, over 70% of them to least developed, low and middle income countries.

No comments yet.